Company Filing History:
Years Active: 2023
Title: Mima Mujacic: Innovator in Cell Surface Glycosylation Assessment
Introduction
Mima Mujacic is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of cell biology, particularly in the assessment of cell surface glycosylation. Her innovative work has implications for various applications in biotechnology and medicine.
Latest Patents
Mujacic holds a patent titled "Methods for assessing cell surface glycosylation." This patent provides methods for assessing cell surface glycans, such as N-glycans, by analyzing a sample of released surface glycans. The methods allow for the determination of the presence, absence, or level of glycans in the sample. Additionally, the patent includes methods for assaying and evaluating a cell composition by assessing the cell surface glycan profile and comparing it to a reference sample. Furthermore, it outlines methods for manufacturing and culturing a plurality of cell compositions with consistent surface glycan expression and low variability.
Career Highlights
Mima Mujacic is currently employed at Juno Therapeutics GmbH, where she continues to advance her research in cell biology. Her work at Juno Therapeutics focuses on innovative approaches to cell therapy and biotechnology.
Collaborations
Mujacic has collaborated with notable colleagues, including Paul Ken Kodama and Tom Kowski, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Mima Mujacic's contributions to the field of cell surface glycosylation assessment highlight her role as an influential inventor. Her patent and ongoing work at Juno Therapeutics GmbH demonstrate her commitment to advancing scientific knowledge and technology in biotechnology.